Pharmacist-Led Discharge Care to Reduce Postdischarge Health Care Utilization
JAMA Network Open 10.1001/jamanetworkopen.2026.0719March 17, 2026 at 11:00 AM EDT
Pharmacist-led peridischarge transitions of care (TOC) interventions reduce adverse drug events after hospital discharge, but do they reduce readmissions and other health care utilization?This randomized clinical trial included 6478 patient hospitalizations among adults aged 55 years or older with polypharmacy or taking high-risk medications, randomized to either usual care (admission medication reconciliation) or pharmacist-led medication review, discharge medication reconciliation, and addressing of medication adherence and safety. No significant between-group difference was detected in all-hospital unplanned 30-day postdischarge health care utilization.Among older adults with polypharmacy, a pharmacist-led TOC intervention did not reduce 30-day unplanned health care utilization after hospital discharge.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.